David C. Olson, PhD — President and Chief Executive Officer
David is a serial entrepreneur who has co-founded 6 biotech start-ups, managed other early-stage businesses, and authored business plans backed by more than $50M private and $2M public funding. He specializes in commercializing life science technologies and has more than 15 years experience in company building, life science research and product development, intellectual property management, business development and venture financing. Most recently he was a founding member and senior executive of Accuri Cytometers (acquired by Becton Dickinson in 2011), which developed a successful product line of flow cytometers (life science research tools). David was responsible for creating Accuri’s product vision and played a central role in all aspects of corporate strategy, including financing and business development.
David received his doctorate in Molecular Biology from Princeton University, completed a postdoctoral fellowship at the University of California, San Francisco, and is currently Adjunct Faculty at the University of Michigan Medical School.
Vladimir Makarov, PhD — Chief Scientific Officer
Vladimir has a track record of developing novel research and diagnostic methods and tools. His experience spans more than 30 years in cutting edge molecular biology and life science research, with broad expertise in different fields of science including physics, molecular biology, genomics, and molecular diagnostics. Vladimir has authored more than 30 issued and pending patents and 60 scientific publications. He has co-founded 2 biotech start-ups, leading to development and commercialization of more than 10 different products in the research tools and diagnostics space. Prior to Swift, Vladimir served as Chief Scientific Officer of Rubicon Genomics, and was the key inventor of Rubicon products. Vladimir was responsible for creating Rubicon’s product vision, research and development, and intellectual property management.
Vladimir received his PhD in Physics and Mathematics from St. Petersburg University and has held senior scientist positions at the University of Michigan (Ann Arbor) and the Institute of Molecular Biology (Moscow).
Steve Spotts — Chief Commercial Officer
Steve is a seasoned executive with 30 years of sales and marketing experience in the life sciences. Prior to joining Swift, Steve was Commercial Modality Leader for label-free products at GE Healthcare. Prior to GE, Steve was Vice President, Sales and Marketing at MicroCal, where he was responsible for business development, sales, marketing, applications support and customer service. During his tenure at MicroCal, Steve revamped their commercial operations and penetrated new markets by developing new applications for microcalorimetry systems in conjunction with key customers and thought leaders. Steve has also served as a management consultant to the life science industry on a broad spectrum of products and services with clients ranging from start-ups to Fortune 100 companies. Prior to becoming a consultant, Steve served as Vice President of Sales and Marketing and Vice President of Marketing at Pharmacia Biotech, now part of GE Healthcare.
Steve possesses an MBA in marketing from Loyola College, an MS in biology from Shippensburg State College and a BS in biology from Dickinson College.